potassium-sparing diuretics	is a	diuretic
potassium-sparing diuretics	subclass of	antihypertensive drugs
potassium-sparing diuretics	mechanism	aldosterone antagonism
potassium-sparing diuretics	treats	hypertension
potassium-sparing diuretics	treats	heart failure
potassium-sparing diuretics	prevents	hypokalemia
potassium-sparing diuretics	contraindicated in	hyperkalemia
potassium-sparing diuretics	interacts with	ACE inhibitors
potassium-sparing diuretics	interacts with	potassium supplements
potassium-sparing diuretics	example	spironolactone
spironolactone	blocks	mineralocorticoid receptors
spironolactone	treats	ascites
spironolactone	side effect	gynecomastia
potassium-sparing diuretics	example	amiloride
amiloride	inhibits	epithelial sodium channels
amiloride	used for	lithium toxicity
potassium-sparing diuretics	example	triamterene
triamterene	causes	nephrolithiasis
triamterene	metabolite	sulfate conjugate
potassium-sparing diuretics	onset	slow
potassium-sparing diuretics	duration	long
potassium-sparing diuretics	prescribed with	thiazides
thiazides	cause	hypokalemia
hypokalemia	leads to	arrhythmia
potassium-sparing diuretics	monitoring	serum potassium
hyperkalemia	risk factor	renal impairment
renal impairment	requires	dose adjustment
potassium-sparing diuretics	absorption	oral
potassium-sparing diuretics	protein binding	high
spironolactone	metabolized by	CYP3A4
CYP3A4	inhibited by	grapefruit juice
potassium-sparing diuretics	excretion	renal
potassium-sparing diuretics	half-life	10-35 hours
spironolactone	active metabolite	canrenone
canrenone	duration	72 hours
potassium-sparing diuretics	pregnancy category	C
pregnancy category C	indicates	risk not ruled out
potassium-sparing diuretics	lactation caution	present
potassium-sparing diuretics	cost	low
potassium-sparing diuretics	availability	generic
generic drugs	have	bioequivalence
potassium-sparing diuretics	formulation	tablet
tablet	may contain	lactose
lactose	causes	intolerance
potassium-sparing diuretics	storage	room temperature
potassium-sparing diuretics	brand name	Aldactone
Aldactone	manufacturer	Pfizer
potassium-sparing diuretics	brand name	Dyrenium
Dyrenium	contains	triamterene
potassium-sparing diuretics	research use	acne treatment
acne treatment	involves	androgen suppression
spironolactone	anti-androgenic effect	significant
anti-androgenic effect	treats	hirsutism
hirsutism	associated with	PCOS
PCOS	feature	insulin resistance
insulin resistance	managed by	metformin
metformin	interaction	minimal
potassium-sparing diuretics	trial use	cancer therapy
cancer therapy	target	MR expression
MR expression	elevated in	breast cancer
breast cancer	therapy	hormone blocking
potassium-sparing diuretics	effect	fibrosis reduction
fibrosis reduction	beneficial for	cardiac remodeling
cardiac remodeling	occurs in	myocardial infarction
myocardial infarction	treatment	beta blockers
beta blockers	combination therapy	common
combination therapy	improves	outcomes
outcomes	measured by	ejection fraction
ejection fraction	indicator	heart function
heart function	assessed by	echocardiogram
echocardiogram	uses	ultrasound
ultrasound	performed by	cardiologist
cardiologist	specializes in	heart diseases
heart diseases	include	cardiomyopathy
cardiomyopathy	managed by	diuretics
diuretics	reduce	fluid overload
fluid overload	symptom	edema
edema	visible in	ankles
ankles	swelling	pitting
pitting edema	graded	1-4
grading system	used for	assessment
assessment	determines	treatment
treatment	adjusted based on	response
response	monitored by	weight
weight	increase indicates	fluid retention
fluid retention	managed by	sodium restriction
sodium restriction	part of	DASH diet
DASH diet	recommended for	hypertension
hypertension	complication	stroke
stroke	prevented by	BP control
BP control	achieved by	medications
medications	include	diuretics
diuretics	first-line for	uncomplicated hypertension
uncomplicated hypertension	common in	elderly
elderly	sensitive to	side effects
side effects	include	dizziness
dizziness	leads to	falls
falls	cause	fractures
fractures	risk factor	osteoporosis
osteoporosis	prevented by	calcium
